PROTECT2: Diabetes Care - Eye Exam

Status unconfirmed · Not applicable

Conditions studied: Diabetic Retinopathy, Diabetic Macular Edema

In brief

The PROTECT2 pilot study is a single cohort prospective study to gather pilot data and finalize operational details of the main study. The PROTECT2 main study is a prospective randomized controlled multi-center three group clinical trial. The primary endpoint is the percentage of participants in each study group obtaining a qualified eye examination within 12 months of their enrollment in the study.

Key facts

Study ID

NCT03094819

Run by

Retinal Care Inc.

People needed

4500

Starts

2016-03-17

Expected to finish

2023-12-31

Last updated by the study team

2022-04-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed diabetes using the criteria documented in the 2016 Physician Quality Reporting System (PQRS) Measure Specifications Manual for Claims and Registry Reporting of Individual Measures.
• 18 through 75 years of age
• Have a PCP appointment scheduled within 90 days of the date of medical record review.

You may not qualify if…

• Patients not diagnosed with diabetes
• History of photosensitive epilepsy
• Inability or unwillingness of the participant to give verbal or written informed consent.

Where it is running

• Dean McGee Eye Institute — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.